The subject of the order is the successive delivery of medicines to the hospital pharmacy - according to the name and quantity specified in the pricing tasks. The subject of the order has been divided into tasks. The Employer allows partial bids for tasks ie No. 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14 or on individual items of sentence No. 2 or combined items in task no. 3

General medications - specified in detail in the price form - Annex No. 2 - Task No. 1

Filgrastim - described in detail in Annex No. 2 - price form

Lipegfilgrastym - described in detail in Annex No. 2 - price form

Ondansetronum - described in detail in Annex No. 2 - price form

Ketoprofen - described in detail in Annex No. 2 - price form

Prednisoloni hemisuccinas - described in detail in Annex No. 2 - price form

Furosemide - described in detail in Annex No. 2 - price form

Netupitant / palonosetron - Strips for monitoring blood glucose levels

Strips for monitoring blood glucose levels - described in detail in Annex No. 2 - price form

Metronidazole - described in detail in Annex No. 2 - price form

Etoposide - described in detail in Annex No. 2 - price form

Amikacin - detailed description of attachment No. 2 - price form task # 2

Cisplatin - described in detail in Annex No. 2 - price form

Carboplatin - described in detail in Annex No. 2 - price form

Docetaxel - described in detail in Annex No. 2 - price form

Gemcitabinum - described in detail in Annex No. 2 - price form

Paclitaxelum - described in detail in Annex No. 2 - price form

Doxorubicin h / ch - described in detail in Annex No. 2 - price form

Cyclophosphamide - described in detail in Annex 2 - price form

Topotecanum - described in detail in Annex No. 2 - price form

Pemetrexedum - described in detail in Annex No. 2 - price form

Vinorelbine - described in detail in Annex No. 2 - price form

Cefotaxime

Irinotecan - described in detail in Annex No. 2 - price form

Medicines p / tuberculous - described in detail in Annex No. 2 - price form

Infusion fluids - described in detail in Annex 2 - price form

LEKI p / thrombotic-nadroparin - described in detail in Annex No. 2 - price form

P / thrombotic (dalteparin) - described in detail in Annex No. 2 - price form

P / infectious - described in detail in Annex No. 2 - price form

Antibiotics ciprofloxacin - described in detail in Annex No. 2 - price form

Beta-lactam and glycopeptide antibiotics - described in detail in Annex No. 2 - price form

Task No. 11 - pantoprazole - described in detail in Annex No. 2 - price form

DRIVING AID - described in detail in Annex 2 - price form

Ciprofloxacin lactate - described in detail in Annex No. 2 - price form

Nivolumab - drug program - described in detail in Annex No. 2 - price form

Atezolizumab - drug program - described in detail in Annex No. 2 - price form

Levofloxacinum - described in detail in Annex No. 2 - price form

Clindamycin h / chl. - described in detail in Annex No. 2 - the price form

Imipenem + Cilastatin - described in detail in Annex No. 2 - price form

Albumin - described in detail in Annex No. 2 - price form

Human immunoglobulin at least 96% IgG - described in detail in Annex No. 2 - price form